What3words divides the globe into a grid of 57 trillion squares measuring three metres by three metres and gives each one a unique, 3 word name.
The app uses the GPS on your mobile phone to display your approximate position on a map, which you can then zoom in on and pinpoint more precisely. It then gives you the 3 word address for the square you're in.
The reason the emergency services recommend What3words is that it can save them precious time getting to the scene of an accident. There are obvious benefits for veterinary surgeons too, not just when called to remote locations, but also when a client's postcode is ambiguous.
What3words is free of charge and can be downloaded for Android and Apple phones. There is also a What3words website, what3words.com, which provides the same service, but that only works online (whereas the app works offline too).
I've reviewed the app in more detail on YouTube here:
The Allium species includes onions, garlic, and their relatives. All members of the Allium family are poisonous to cats and dogs and even minimal amounts can be dangerous. For example, a 5kg cat would only need to ingest 1-2 garlic cloves to show clinical signs. Poisoning causes haemolytic anaemia with treatment being supportive, as there is no antidote. In severe cases blood transfusions may be required.
Powdered versions of these plants are more concentrated and are often used in gravy and stuffing in the traditional Christmas dinner, so toxicity can occur much more easily.
Will Peel, Product Manager at TVM UK said: "Alliums are toxic to animals and as there is no antidote it’s important that veterinary staff are fully prepared and are able to react quickly and provide the best care possible.
"Our focus is on helping veterinary staff prepare for all eventualities so we hope that these new guidelines will prove beneficial."
The guidelines can be downloaded for free from https://www.tvm-uk.com/vet-resource-library/.
Animal Friends is launching a pilot programme through which its customers will be able to check their pets' symptoms, get advice on treatment or find out if they need to visit a vet clinic on Joii.
Paul Hallett, co-founder of Vet-AI said: "Animal Friends is a perfect partner for Vet-AI, not only do we share common goals around animal welfare and the profession as a whole, but strategically we are both laser focused on the customer. In the coming few years we will support their customers by providing them with 24 hour expert-led care, at the click of a button. This will drive our business forward, helping us reach more pet owners and improve the care their pets receive."
Wes Pearson, Managing Director of Animal Friends said: "This partnership demonstrates our commitment to provide our pet parents with innovative options to ensure their pet receives the best care. Being able to access professional advice from the comfort of their own home and at a time that suits them can dramatically reduce stress for both the pet and the pet parent. We are excited to be working with Vet-AI and believe that the Joii app will bring expert knowledge and extra peace of mind to our customers."
Oh no, not another company talking about 'pet parents'. Is it just me, or is it not rather patronising?
On 9 April, the College published a flowchart to help veterinary professionals to decide whether or not to carry out a particular type of work, whilst ensuring the health of their teams and clients, and working to uphold animal health and welfare.
The flowchart has been updated as follows:
Firstly, the box that previously said:
‘Can you effectively support the case while maintaining social distancing for your team and the public?’
now says:
‘Can you effectively support the case while abiding by the appropriate social/physical distancing guidance for workplaces to protect your team and the public?’
The College says this new wording better reflects the different language and varying guidance in place across devolved nations. It also recognises that the new government guidance is not just about maintaining a 2m distance, for which ‘social distancing’ appears to become a shorthand, but accepts that other biosecurity measures might be appropriate if the 2m rule cannot be followed in the workplace.
Secondly, the box that previously said:
‘Could the planned intervention have animal health and welfare or public health implications if not carried out within two months?’
‘Could the planned intervention have animal health and welfare or public health implications if not carried out?’
This change recognises that this phase of lockdown-exit may carry on for longer than a two-month period; it therefore leaves it to the clinician’s professional judgement in terms of the implications versus the risk, rather than seeing it within a specific time-period.
RCVS President Niall Connell said: "I’m grateful to the members of our Covid-19 Taskforce for continuing to keep under review our key guidance to the profession during the ongoing pandemic. Whilst these latest changes do not represent any significant changes for vets and vet nurses as they continue to care for the nation’s animals, it is important that we continually keep our guidance in line with that of the UK’s governments."
The updated flowchart is available to view and download from www.rcvs.org.uk/coronavirus.
The video has now been published on Youtube, from where veterinary practices might like to share it with clients on their own websites, by email or on their Facebook page.
In the video, Cat Henstridge MRCVS explains how from November, in the event of no deal, pet owners will need to have visited their vet 4 months before travel and had their pet vaccinated against rabies. They will then need to return for a blood test 30 days later, wait at least 3 months after that test before travel, and get an animal health certificate no more than 10 days before travel. In addition their animal needs to be microchipped.
Defra says owners should also be advised to visit gov.uk and search 'pet travel' for any updates.
Christine Middlemiss, UK Chief Veterinary Officer, said: "This is a reminder for pet owners of our practical and straightforward advice for pet travel if the UK were to leave the EU in a no-deal situation."
To watch and share the video: https://www.youtube.com/watch?v=8Ckhv5YS7Mw.
The company is making the claim based on a £20,000 study it conducted with three dermatology specialists from three different clinics, in different parts of the country.
Trevor Hardcastle, Vet-AI’s chief data scientist said: "We have undertaken a small-scale trial of remote diagnosis of dermatology conditions by veterinary dermatology specialists in canine patients, which has resulted in almost perfect agreement. No significant evidence was found that veterinary dermatology specialists are measurably compromised in their ability to accurately diagnose common dermatology conditions by being remote from the patient."
Strangely, given the strength of the claim, its importance and Vet AI's obvious vested interest in the result, there was no other information contained within the company's press release. No mention of who the specialists were, nothing about the study design, and nothing about the basis on which the claim is made.
However, presuming the company meant Specialists not specialists, it would be very unusual if they had agreed for an announcement of this importance to be made without the evidence being reasonably robust. So it's probably worth suspending judgement until the study is published in full.
Meantime, the company also says its own research into online diagnosis amongst pet owners has shown that more than 50% of people have avoided taking their pets to the vet for cost reasons, yet more than 65% have tried online self-diagnosis. Again, Vet AI doesn't reveal how many pet owners were asked, or how they were sampled.
Vet-AI co-founder Sarah Warren said: "Things like dermatological issues are beautifully aligned to remote consultation because they’re visual so we can gain a wealth of information from images and distribution maps and easily recommend treatments.
"This needs to happen in a regulated, ethical and correct way with a view to improving animal welfare.
"The RCVS has a chance to ensure that people have access to quality vet help online in an effective way. They can do this, or they can allow them to continue accessing poor-quality advice. As a profession, it’s vital we respond to the needs of pet owners."
Participating practices will learn about dental disease pathophysiology and diagnosis, gain insights in pet owner behaviour and learn how to increase client engagement while implementing a dental home care plan.
Animalcare has also made available free social media packs and waiting room materials to help educate clients on pet dental health.
Will Peel, Marketing Manager at Animalcare said: ‘We know that UK veterinary surgeons consider dental disorders to be one of the most important health related welfare issues currently affecting UK dogs.
"We’ve introduced our CPD sessions to help the entire veterinary team learn more about dental disease and to help them educate their clients about implementing an at home dental regime which works for them and their pets.'
To book your Lunch and Learn or request a social media pack and other materials, contact your local Animalcare territory manager or email animalcare@animalcare.co.uk.
With Vetscan Imagyst, samples are prepared in-clinic using traditional methods, but submitted digitally, rather than sending physical slides to a laboratory. In this way, results are available in hours, allowing vets to offer same-day diagnosis and treatment.
The company says the new digital cytology application offers fast, accurate reviews of common cytology specimens, such as fine-needle aspirates,
Jamie Brannan, President International Operations, Zoetis said: "Veterinarians have told us that Vetscan Imagyst technology helps them make better informed decisions in a more transparent way for pet owners. With the cytology feature, Vetscan Imagyst will now offer one platform for multiple tests.”
He added: “We are excited to build on the incredible momentum that began with the AI fecal analysis launch. Vetscan Imagyst has been a significant part of the Zoetis portfolio and continues to evolve to meet diagnostic needs in practices around the world. The unique all-in-one technology has added immense value to veterinary clinics, facilitating fast, more accurate results, leading to quicker diagnoses and decisions that ultimately strengthen the bond of trust between veterinarians and their clients.”
For more information, contact your Zoetis representative or visit www.vetscanimagyst.com
‘Is neutering dogs doing more harm than good?’ (BVA Congress Theatre, Thursday 16th November 2023 at 10.30am), will explore the latest research into the science of neutering and its impact on dog health and welfare, particularly on behaviour, and will also consider the role of non-surgical alternatives.
The session will be chaired by BVA President Dr Anna Judson, joined by:
The BVA says statistics from its Voice of the Veterinary Profession survey show that among clients who chose to neuter their dogs last year, only 6% picked non-surgical options.
Awareness of these options is low, with vets reporting that 9% of their clients had requested information about non-surgical options when considering neutering, such as sustained-release implants to suppress testosterone production in male dogs.
Among those who considered non-surgical options, clients cited the cost and need for repeat treatments as their main concerns (mentioned by 67% and 58% of vets, respectively), followed by individual variation in the effect and duration of non-surgical alternatives (22% of vets).
Anna said: “Canine neutering is a firmly established part of preventive pet healthcare in the UK, but it is also very much a live discussion within the veterinary profession, with a healthy ongoing debate around its merits and risks, based on evolving evidence.
"BVA’s survey shows low awareness among clients about all available neutering options for their pets, with only a tiny percentage choosing to go down the non-surgical route.
“Our BVA Congress discussion will offer vet professionals in small animal practice insight into the latest research on neutering, including potential longer-term impacts on a dog’s health and behaviour, and views on what that might mean for how vets discuss neutering options with clients.
"The panellists will also share useful tips on how to deal with clients’ questions about surgical and non-surgical options for their pets.”
https://bvajournals.onlinelibrary.wiley.com/toc/20427670/2023/193/S1
Bayer Animal Health has doubled the number of pipettes in its Advocate all-in-one flea, worm and mite spot-on to provide an additional range of six-month treatment packs for cats and dogs. Bayer says the doubling of the number of pipettes in a pack is aimed at providing vets with greater prescribing flexibility and to help improve compliance for owners over a six-month period. Bi-annual vet visits will now give a full year's parasite cover with Advocate. Advocate is now available in three- and six-pipette packs for small and large cats and for medium, large and extra large dogs, and three-pipette packs for small dogs. The product remains the only combined flea, worm and mite spot-on that is licensed for the treatment of A. vasorum in dogs.
The College says the course breaks down the supporting guidance to the Code of Professional Conduct into clear, practical advice that can be easily applied in daily practice.
It covers areas such as advertising, endorsing products and services, and using social media in a way that upholds professional standards, including:
The course begins with a short test to assess your current understanding of the topic, followed by three bite-sized modules and a final reflection section.
The course takes about an hour to complete and counts towards your CPD requirements.
academy.rcvs.org.uk
The divestment is expected to be concluded in mid-2020, and Bayer intends to exit its stake in Elanco over time.
Bayer says that combining Elanco and Bayer Animal Health will create the number two animal heath company, with top three positions across a broad range of species and geographies. It also enhances Elanco’s portfolio of leading global brands and bolsters its innovation capabilities and R&D pipeline.
Jeffrey N. Simmons, president and chief executive officer of Elanco, said: "Combining Elanco’s strong relationship with veterinarians and Bayer’s leadership in retail and e-commerce will ultimately benefit all our customers. We look forward to joining our complementary portfolios and capabilities to build a fully focused animal health company, providing a sustained flow of innovation for farmers, veterinarians and pet owners."
Chair of the Standards Committee, Dr Melissa Donald, said: “We were very aware of the likelihood that both practice staff and clients will increasingly have to isolate over the coming weeks due to direct infection or positive contacts, particularly with the rise in cases amongst school children.
“Added to this, we know there are already workforce pressures across the profession, which will be exacerbated by reduced staffing levels over the Christmas and New Year period.
“We therefore felt it was appropriate to reintroduce these temporary remote prescribing measures at this time to help relieve pressure on practising professionals, and to provide them with the means to continue to look after the health and welfare of their patients in all circumstances.”
As before, the temporary dispensation is subject to the specific guidance found in FAQ4 (www.rcvs.org.uk/covidfaq4), including that veterinary surgeons must be able provide a 24/7 follow-up service involving physical examination, for example where the animal does not improve, or suffers an adverse reaction, or deteriorates, subsequent to the remote prescription of medicines.
The Committee agreed that the position should be reviewed in February 2022 at its next meeting.
VetYogi’s new ‘VetYogi Collective’ offers an on-demand online hub of yoga, mental health and wellbeing sessions designed to meet the individual needs of RVNs, vets, practice managers, receptionists, students and paraprofessionals.
Subscription includes a monthly live yoga session and access to a library of content which includes yoga sessions lasting from minutes to over an hour.
There are also videos, and advice on guided meditation to help support wellbeing and manage stress.
Chloe says: “It’s important that everyone who has a need, has access to the type of wellbeing tools that they respond best to, so we have developed self-care sessions for all roles in the profession.
"If you have had a hard day or a stiff neck from working in theatre for hours, or are just feeling tense and unable to switch off, you need help there and then.
"The VetYogi Collective provides that support around the clock which we simply couldn’t deliver any other way.”
Individual subscriptions cost £12 per month.
Practices signing up their team are offered preferential rates and can use the VetYogi Collective badge on their materials to signal their commitment to supporting wellbeing.
collective.vetyogi.com
Speakers at the event will include Andrew Sparkes, BVetMed, PhD, DipECVIM, MANZCVS, MRCVS (pictured right) and Ebenezer Satyaraj, PhD.
BSAVA Congress delegates can register for the free symposium, which also includes lunch, at www.tickettailor.com/events/purina/349478.
Libby Sheridan, MVB MRCVS, Purina Veterinary Technical Affairs Manager, said: "Veterinary professionals often see the consequences of sensitivities to cat allergens - which for some, it may even mean relinquishment of the pet with all the emotion attached around that event. This symposium will focus on the consequences for cat welfare and how the profession can help support their cat-owning clients through a breakthrough approach."
The new approach is based on neutralising the major cat allergen in cats' saliva, Fel d 1, through feeding a cat food coated with an egg product ingredient containing anti-Fel d 1 antibodies.
This, says the company, helps to reduce the active allergen transferred to hair and dander during grooming, and ultimately helps reduce active Fel d 1 in the environment.
Dr Sparkes is a diplomate of the European College of Veterinary Internal Medicine and the founding and current co-editor of the Journal of Feline Medicine and Surgery, the official journal of ISFM and the American Association of Feline Practitioners. He will be sharing his review of the literature around feline relinquishment.
Dr. Satyaraj is a member of the American Association of Immunologists and the American Veterinary Immunology Association and a reviewer for several journals including the British Journal of Nutrition and Arthritis & Rheumatism. He is also a Fellow of the Academy of Science in St Louis and a leading scientist at the Purina Institute. Dr Satyaraj will be focusing on the studies supporting this important area of research.
The symposium provides 1.5 hours of certified CPD. More information about the science is available at www.purinainstitute.com.
For the study, 12 month's worth of anonymised data from CVS practices was analysed2.
The study concluded that lower engagement between a practice and its staff or clients, recent parental leave, shorter practice employment tenure, and younger age were all associated with an increased likelihood of support staff resignations.
Lower practice client engagement, which CVS says is a proxy for client satisfaction, was associated with increased odds of support staff resigning3, highlighting the potential impact of client incivility on veterinary colleagues who are typically in customer facing roles.
Reduced employee engagement – measured by a ‘employee net promoter score’ (eNPS), where colleagues rate how likely they would recommend the practice as a good place to work4, also correlated with increased resignations.
Within CVS, eNPS has been demonstrated to be positively correlated with the frequency of line manager discussions.
The current data suggests that consistent measurement of employee engagement in a veterinary setting at regular intervals throughout the year can have benefits for line managers in identifying increases in the risk of resignations and practice attrition, allowing them to take proactive steps to improve engagement.
A recent record of taking parental leave was also associated with greater odds of resigning in the following 12 months than staff who have not taken parental leave in the previous 12 months5.
Qualitative studies in other professions highlight the need for greater flexibility in working hours and focused managerial check-in support.
Therefore ‘return to work’ interventions may present an opportunity to improve retention.
Conversely, the increased length of employment tenure was associated with decreasing odds of support staff resignations6, potentially highlighting the role for long service reward schemes, such as the long service holiday awards CVS introduced a couple of years ago. Whilst employee age was associated with the odds of resignations, with a 1% decrease in the odds of support staff resigning with each additional year of age7.
Imogen Schofield, Director of Clinical Research at CVS, said: “Support staff are integral members of the team.
"These key roles contribute to the efficient and effective functioning of a veterinary practice.
"Despite the important roles of support staff, little research exists on these team members and there is no data describing reasons for their attrition.
“This research was done to help the wider industry to understand how we can reduce support staff resignations.
"It aims to identify demographic, payroll and engagement factors associated with resignations.
"We believe it adds valuable insights to previous survey-based research by organisations such as the British Veterinary Receptionist Association.
“Reflecting on our research from 2021, we have introduced a Zero Tolerance Policy to protect our colleagues against intrusive, offensive, violent or aggressive behaviour from clients.
"We have launched monthly interactive Receptionist Support Sessions, giving receptionists the opportunity to connect with their peer network, share experiences and ideas, and feel supported.
"And we are now focussing on developing our support staff through creating new Receptionist and Patient Care Assistant Career Pathways.”
References
Vet Sustain works to inspire and enable veterinary professionals to become leading forces in sustainability and improve the health and wellbeing of animals, people and the environment.
To that end, the company produces tools, training and communications for veterinary professionals centred around its six Veterinary Sustainability Goals (SDGs):
Gudrun Ravetz, Chair and Director of Vet Sustain, said: “We are very pleased to announce IVC Evidensia as a strategic partner of Vet Sustain.
"Veterinary professionals sit at the One Health triumvirate of people, planet and environment every day and working with IVC Evidensia will allow Vet Sustain to continue work on ambitious projects to support veterinary professionals to be active sustainability champions.”
You can find out more about IVC's Sustainability Report here: https://ivcevidensia.com/how-we-work/sustainability/
The company says the two main benefits of the liquid formulation are precise dosing and ease of administration.
Vetmedin oral solution comes with a kg-bodyweight calibrated syringe to make it easy to give the preferred dose of 0.25 mg/kg twice daily to the nearest 0.5 kg bodyweight.
The maximum syringe volume is for a 12 kg dog.
The solution has a sweet taste to make it palatable and Boehringer says it is also ideal for dogs that need dental work but require treatment for their heart disease before general anaesthesia.
These dogs might struggle to eat chewable tablets due to oral discomfort, so a liquid treatment might be a better option.
The company highlights the EPIC1 and PROTECT2 studies which showed that Vetmedin delays the onset of CHF for dogs in the asymptomatic stage of heart disease and improves both the quality and length of life for dogs with MVD and DCM.
Vetmedin oral solution comes as a 50 ml bottle (each bottle lasts a 5 kg dog approximately 30 days), doesn't need to be refrigerated, has an 8-week shelf life once opened, and a 2-year shelf life as packaged.
VetMedin oral solution is now available to order from wholesalers.
The study1 investigated the effects of a weight loss programme on biochemical and immunological profile, blood leptin level, and cardiovascular parameters in a cohort of dogs with naturally occurring obesity, in order to address the effects due to the imbalance of these aspects on the clinical presentation and management of canine obesity.
For the study, eleven obese, but otherwise healthy dogs were included in a six-month weight loss programme, together with a control group of eleven healthy dogs at ideal body condition.
After the six-month weight loss programme, the obese dogs showed clinical improvements on a number of key indicators related to immune function, such as reduced tumour necrosis factor (TNF)-α and interleukin (IL)-6, known to impair insulin action in metabolic tissues but also favour cancer development in humans. Ten out of eleven showing a reduced BCS and no longer classified as obese.
Ten out of eleven dog owners also reported that their dogs were more active and that their quality of life had notably improved.
Hugues du Plessis, Pet Obesity Prevention Manager, at Purina said: “Preventing pet obesity is a major focus at Purina. We not only want to be providing pet owners with information on the benefits of a healthy pet lifestyle, but we also want to help them achieve it. This is why we are working with partner organisations to understand how behavioural science can be used to support owners, from the recognition of an issue, to the changes that will make a difference".
Reference:
The programme includes:
Chris Scudder will also be announcing the successful bids for funding from SAMSoc's new research grant initiative.
Co-organiser Caroline Kisielewicz (pictured right) said: "Despite the trials and tribulations of the ongoing pandemic, we are delighted that the spring SAMSoc meeting has returned this year! We are very excited about the upcoming meeting, which is packed full of great lectures that will stimulate some great talking points. Whilst it won't be the same as being there in person, we hope that everyone will enjoy connecting with colleagues and friends through the virtual world with what promises to be a fantastic event."
The association is also inviting entries now for the next poster/case report competition, details of which can be found at: https://www.samsoc.org/competitions/call-for-spring-2021-poster-entries.
The winning presentation will receive £250, and two runners up will each receive £100.
For the full programme, visit https://www.samsoc.org/meetings/2021-spring-meeting
Registration costs £100 for the day, with a discounted rate at £60 for SAMSoc members (membership costs £29).
To register, visit www.samsoc.org.
Called the RCVS Academy, the new platform offers training in the following areas:
The College says the content has been developed in partnership with members of the profession to make sure it meets the needs of the veterinary team, including new graduates and registrants, and those who have been in the profession for many years.
Lizzie Lockett, RCVS Chief Executive, said: “As part of our ambition to be a compassionate regulator, we would like to ensure that all veterinary professionals have access to learning resources that will help them meet the standards set by their peers on RCVS Council.
"We’re aware of the pressures that veterinary professions are facing and the Academy has been built to respond to changing learning needs.
“The learning resources available on the platform have been designed to help vet teams develop their understanding of the RCVS professional guidelines and also how they can apply them in their everyday role. "
https://academy.rcvs.org.uk/
The study was a randomised controlled trial of client-owned dogs and cats presenting as emergencies and requiring intravenous catheterisation.
Patient signalment and mentation score were recorded.
Patients were randomly allocated to either a swab saturated with vapocoolant spray or a swab saturated with saline applied to the clipped area before intravenous catheterisation.
Indirect application of vapocoolant spray via a swab before catheterisation was not found to significantly reduce the reaction of dogs and cats, nor to improve placement success rates.
The study did demonstrate a significantly greater adverse response to vapocoolant spray application to the skin via a swab when compared with the saline control in canine patients; feline patients demonstrated adverse responses to both vapocoolant spray and saline swabs.
It is unclear if the technique of application used in this study provided sufficient cooling effect to provide the required cryoanaesthesia to influence patient reaction.
The authors say future studies should be used to determine optimal vapocoolant spray application technique in dogs and cats, as well as examine its application in other populations and procedures.
Nicola Di Girolamo, Editor of JSAP concluded: “Pragmatic, adequately-powered, randomised controlled trials like the one presented here are essential to evaluate whether an intervention is not only efficacious in a controlled environment, but also effective during clinical practice.”
Full article: https://onlinelibrary.wiley.com/doi/full/10.1111/jsap.13504
Reference
Trinder, R, Humm, K, Phillips, S, and Cole, L (2022) The efficacy of vapocoolant spray for the improved tolerance of catheter pain in emergency patients in dogs Journal of Small Animal Practice, Available at: https://onlinelibrary.wiley.com/doi/full/10.1111/jsap.13504
The research, which was carried out by analysing data from 455,557 dogs which presented at veterinary practices participating in the College’s VetCompass programme, investigated the frequency, severity and duration of anal sac disorder, conjunctivitis, dental disease, dermatitis, obesity, lipoma, osteoarthritis and otitis externa.
The main findings were:
The most common conditions were dental disorder (9.6%), overweight/obese (5.7%) and anal sac disorder (4.5%)
The conditions that lasted the longest were dental disorders (76% of year), osteoarthritis (82%), and overweight/obese (70%)
Scoring out of 21, with higher scores for greater severity, the most severe conditions were osteoarthritis (13/21), otitis externa (11/21) and dermatitis (10/21).
The researchers say that by considering frequency, duration and severity together, the study showed that the conditions with the highest welfare impact overall are dental disease, osteoarthritis and obesity.
It is hoped these results can help vets to target conditions that have the greatest impact on dogs they treat. The evidence also shows owners the value of addressing these important conditions to improve their animal’s welfare. The study also provides evidence for other stakeholders on which conditions merit further research prioritisation.
Dave Brodbelt, Professor of Evidence-based Veterinary Medicine at the RVC and senior researcher on the study, said: "First opinion veterinary professionals see dogs presenting to them with a range of conditions everyday and understand what are the common diseases that they treat. Yet there is a need for clear evidence based welfare assessment of the major conditions of dogs. This work adds to our understanding by allowing the transparent comparison of commonly seen disorders in primary practice and highlights conditions with greatest welfare impact."
Dr Dan O’Neill, Senior lecturer in epidemiology at the RVC and co-author said: "During my 20 years as a first opinion vet, owners constantly asked me to advise them about the most important conditions that they should try to prevent in their dogs. At that time, I could not answer this as it was unknown to science. We now have this answer; and we can now advise owners to focus on dental health, monitoring for joint disease and to pay special attention to their dogs body condition score. Finally, we have the key to prioritising long-term health in dogs overall. This is a huge step forward to improving dog welfare; huge thanks to Dogs Trust for having the vision to support this work."
The study is freely available open access.
The company says the new product has been 10 years in development and uses 'Soft Mist' technology - developed originally for human use by its pharma business - to deliver medication deep into the horse's lungs.
The active ingredient in the Aservo EquiHaler is ciclesonide, a corticosteroid that is activated directly in the lung, reducing the lower airway inflammation associated with severe equine asthma and reducing the risks commonly associated with systemic corticosteroids.
The Aservo EquiHaler does not use a propellant, so it does not contribute to greenhouse gas emissions. Boehringer also highlights that it is made from up to 50% recycled materials. In April, the product was awarded a Red Dot Design Award.
Dr Marc Laemmer, Head of Equine in UK & Ireland said: "It's another industry first and is a strong indicator of the commitment that Boehringer Ingelheim has to the health and welfare of horses, and to the investment that we make into continuing to advance therapies through collaboration and innovation.
"We understand that a product launch in this challenging time for the veterinary profession may seem surprising, but we have had such strong demand from equine vets for the product that we have committed to making Aservo EquiHaler available. Out team of territory managers and vet advisers will conduct remote meetings with customers to make sure that they have the information and support they require."
According to the Spring 2022 Voice of the Profession survey, one in four cats (24%) seen in practices are not having all of their welfare needs met.
The issues identified by vets as the most pressing at their practice were: